Autopsy report · NCT01288079
A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 6 months before it stopped.
- 145 participants enrolled.
- Results were posted on the registry 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Major Depressive Disorder
- Interventions
- TC-5214; Duloxetine; Placebo
- Participants
- 145
- Sites
- 63
- Countries
- Estonia, Finland, India, Japan, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.